TTOO — T2 Biosystems Balance Sheet
0.000.00%
- $4.04m
- $13.88m
- $7.19m
Annual balance sheet for T2 Biosystems, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 11 | 42.2 | 32.2 | 10.3 | 15.7 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2.83 | 5.1 | 5.13 | 2.16 | 1.42 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 18.9 | 53.6 | 44.4 | 19.4 | 25.2 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 9.21 | 14.8 | 14.4 | 13.3 | 9.05 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 28.5 | 79.1 | 60.5 | 34.3 | 34.8 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 60.6 | 9.8 | 11.7 | 10.1 | 56.2 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 62.5 | 70.4 | 73.4 | 74 | 62.8 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -34 | 8.73 | -12.9 | -39.7 | -28 |
Total Liabilities & Shareholders' Equity | 28.5 | 79.1 | 60.5 | 34.3 | 34.8 |
Total Common Shares Outstanding |